Neuroinflammatory and Synaptic Roles of Glial Cells in Autism Spectrum Disorder

Area of Science:

• Neuroscience
• Immunology
• Developmental Biology

Background:

• Autism spectrum disorder (ASD) is a neurodevelopmental condition.
• Glial cells, including astrocytes, microglia, and oligodendrocytes, are implicated in ASD pathogenesis.
• Glial cell dysfunction contributes to neuroinflammation and synaptic abnormalities in ASD.

Purpose of the Study:

• To systematically review literature on glial cell pathology in ASD.
• To explore the role of glial cells in ASD etiology and pathogenesis.
• To identify potential therapeutic targets for ASD based on glial cell function.

Main Methods:

• Systematic literature review of peer-reviewed studies.
• Searched databases for research on astrocyte, microglia, and oligodendrocyte function in ASD.
• Examined molecular pathways of neurotransmission and neuroinflammation in glial cells.

Main Results:

• Astrocytes show disrupted calcium signaling and increased IL-6, contributing to neuroinflammation.
• Microglia adopt a pro-inflammatory M1 phenotype, releasing neurotoxic cytokines.
• Oligodendrocyte dysfunction leads to aberrant myelination and impaired neural connectivity.
• Molecular mechanisms involve dysregulated TLRs, cytokine signaling, oxidative stress, and glutamate/GABA metabolism.
• Environmental toxins like chlorpyrifos exacerbate glial dysfunction.

Conclusions:

• Glial cell pathology is central to ASD etiology and symptoms.
• Interventions targeting glial dysfunction, such as anti-inflammatory drugs or cell therapy, show therapeutic potential.
• Understanding glial-neuronal interactions and neuroinflammation is key for developing targeted ASD treatments.